Illumina and Genpathway Announce Partnership to Provide Whole-Genome ChIP-Sequencing Services
News May 01, 2008
Illumina, Inc. and Genpathway have announced the formation of a partnership to provide researchers whole-genome chromatin immunoprecipitation (ChIP) sequencing services. Samples are first prepared using Genpathway’s FactorPath ChIP assays, and then sequenced by the Genome Analyzer through Illumina’s Sequencing Services.
Final data analysis is completed by Genpathway using their proprietary software analysis tools. Combined, the Illumina and Genpathway services provide researchers with access to a complete ChIP-sequencing solution for identifying and quantifying transcription factor binding sites across the entire genome.
Specifically, the combined services include cell or tissue processing, antibody selection and qualification, ChIP using Genpathway’s optimized procedures for greater sensitivity and specificity, ChIP DNA amplification, quality-control steps throughout the assay, Sequencing Services using Illumina’s Genome Analyzer, and complete data analysis by Genpathway. Additional information about Illumina’s Sequencing Services with Genpathway’s ChIP assays and data-analysis services can be accessed at www.illumina.com/ChIPsequencingservices.
“We are delighted to team up with Illumina, a world leader in sequencing, to offer the most powerful and comprehensive ChIP-sequencing services available,” said Mary Harper, Ph.D., Chief Scientific Officer of Genpathway. “One of the top applications for sequencing is ChIP, a notoriously time-consuming and difficult procedure. Combining Genpathway’s expertise in ChIP and data-analysis services with Illumina’s high-throughput next-generation sequencing technology and services provides researchers a faster path to discovery.”
Quotient Sciences Acquires Pharmaterials, a UK-based Contract Development and Manufacturing OrganizationNews
Quotient Sciences, the drug development services organization, announces it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, U.K..READ MORE
Researchers Discover Mutation That Appears to Protect Against Multiple Aspects of Biological AgingNews
The first genetic mutation that appears to protect against multiple aspects of biological aging in humans has been discovered in an extended family of Old Order Amish living in the vicinity of Berne, Indiana, report Northwestern Medicine scientists.READ MORE
BOC Sciences Continues to Enlarge Its Publication Collection Using BOC Sciences ProductsNews
BOC Sciences continues to add more publication items that used BOC Sciences products in their researches to its already existing collection.READ MORE